SCHEMBL15316770

SCHEMBL15316770

CC1=CC[C@H](CC=O)C1(C)C

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1782826 1.00 USP2 (0.39) USP2NPSR1TDP1
SCHEMBL16558598 1.00 USP2 (0.39) USP2NPSR1TDP1
SCHEMBL2431308 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2427834 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2424981 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2427596 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2424984 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2428480 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2427837 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2428359 0.83 USP2 (0.35) USP2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023187598-A1 COMPOSITIONS AND METHODS BIBLICAL LANDS LTD (IL) 2023-10-05 WO claimed
EP-3809876-A1 PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME PERPRIN S.R.L. (IT) 2021-04-28 EP claimed
WO-2019243869-A1 PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME PERPRIN S.R.L. (IT) 2019-12-26 WO claimed
US-20260034186-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS RIZUN NODARI (US) 2026-02-05 US disclosed
US-20260027136-A1 CANNABIS BASED THERAPEUTIC AND METHOD OF USE YUZU LV LLC (US) 2026-01-29 US disclosed
EP-4658082-A2 MILKFAT OR BUTTERFAT FORMULATIONS Savor Foods Limited (US) 2025-12-10 EP disclosed
US-12458653-B2 Cannabis based therapeutic and method of use YUZU LV LLC (US) 2025-11-04 US disclosed
US-12427176-B2 Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products RIZUN NODARI (US) 2025-09-30 US disclosed
US-12303488-B2 Cannabis based therapeutic and method of use YUZU LV LLC (US) 2025-05-20 US disclosed
CN-113950465-B Sandalwood type spice compound 西姆莱斯股份公司 2024-09-20 CN disclosed
US-20240294470-A1 FRAGRANCE COMPOUNDS GIVAUDAN SA (CH) 2024-09-05 US disclosed
EP-2655303-B1 HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH TETRADENTATE AMINO/IMINO-THIOETHER BASED RUTHENIUM COMPLEXES FIRMENICH & CIE (CH) 2017-02-22 EP disclosed
US-20160207862-A1 FRAGRANCE COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-07-21 US disclosed
US-20160207862-A1 FRAGRANCE COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-07-21 US disclosed
US-20160207862-A1 FRAGRANCE COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-07-21 US disclosed
EP-3042891-A1 FRAGRANCE COMPOSITION Takasago International Corporation (JP) 2016-07-13 EP disclosed
EP-3042891-A1 FRAGRANCE COMPOSITION Takasago International Corporation (JP) 2016-07-13 EP disclosed
WO-2015034084-A1 FRAGRANCE COMPOSITION 高砂香料工業株式会社 (JP) 2015-03-12 WO disclosed
US-20130274487-A1 HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH TETRADENTATE AMINO/IMINO-THIOETHER BASED RUTHENIUM COMPLEXES FIRMENICH SA (CH) 2013-10-17 US disclosed
US-20130274487-A1 HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH TETRADENTATE AMINO/IMINO-THIOETHER BASED RUTHENIUM COMPLEXES FIRMENICH SA (CH) 2013-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207862-A1 FRAGRANCE COMPOSITION CYP51A1, TRPA1, CYP1A1 USP2 3195/4885NPSR1 1254/4885TDP1 3102/4885
US-20240294470-A1 FRAGRANCE COMPOUNDS FASN, FAAH2, FADS2 USP2 2770/4885NPSR1 1970/4885TDP1 4392/4885
US-20130274487-A1 HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH TETRADENTATE AMINO/IMINO-THIOETHER BASED RUTHENIUM COMPLEXES ADH5, ADH1A, ADH1C USP2 3425/4885NPSR1 3887/4885TDP1 3207/4885
US-20260027136-A1 CANNABIS BASED THERAPEUTIC AND METHOD OF USE CNR1, CNR2, OPRM1 USP2 4554/4885NPSR1 1022/4885TDP1 2027/4885
US-20260034186-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS TRPV1, SOST, RUNX1 USP2 4459/4885NPSR1 1822/4885TDP1 1918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.